The use of Journavx for moderate to severe pain has not been studied beyond 14 days. The Food and Drug Administration (FDA) has approved Journavxâ„¢ (suzetrigine) for the treatment of moderate to ...
Learn more about weight management. Adopting a neutral posture for sitting and standing may help to prevent back pain. If doing this is difficult, a person may benefit from physical therapy to ...
Anxiety can sometimes cause physical symptoms like chest pain and pressure. But because these symptoms can also indicate heart conditions, it’s important to get an accurate diagnosis.
The study met its primary endpoint demonstrating a statistically significant reduction in pain intensity with cebranopadol vs placebo. Topline results were announced from a phase 3 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results